Cisplatin and mild hyperthermia in radiosensitization to low dose rate irradiation in human ovarian carcinoma cells

Anticancer Research

Volumn 17, Issue 5 A, 1997, Pages 3469-3472

  Raaphorst, G P ^a   Miao, J ^a   Ng, C E ^a  

^a OTTAWA REGIONAL CANCER CENTRE   (Canada)

Author keywords

Cisplatin; Hyperthermia; Low dose rate irradiation

Indexed keywords

ANTINEOPLASTIC METAL COMPLEX; CISPLATIN;

ARTICLE; CARCINOMA CELL; FEMALE; HUMAN; HUMAN CELL; HYPERTHERMIC THERAPY; IRRADIATION; OVARY CARCINOMA; PRIORITY JOURNAL; RADIOSENSITIZATION;

CELL SURVIVAL; CISPLATIN; COMBINED MODALITY THERAPY; DOSE-RESPONSE RELATIONSHIP, RADIATION; FEMALE; HUMANS; HYPERTHERMIA, INDUCED; OVARIAN NEOPLASMS; RADIATION, IONIZING; TIME FACTORS; TUMOR CELLS, CULTURED;

EID: 0030729495     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Raaphorst GP, Wang G, Stewart DJ and Ng CE: Concomitant low dose rate irradiation and cisplatin treatment in ovarian carcinoma cell lines sensitive and resistant to cisplatin treatment. Int J Radiat Biol 69: 623-631, 1996.
2. Dewit L: Combined treatment of radiation and cis-diaminedichloroplatinum (II): A review of experimental and clinical data. Int J Radiat Oncol 13: 403-426, 1987.
3. Nias AHW: Radiation and platinum drug interaction. Int J Radiat Biol 48: 297-314, 1985.
4. Dritschilo A, Piro A and Kelman AD: The effect of cisplatinum on the repair of radiation damage in plateau phase Chinese hamster V79 cells. Int J Radiat Oncol 5: 1345-1349, 1979.
5. Wilkins DE, Raaphorst GP and Heller DP: Inhibition of potentially lethal damage recovery by cisplatin in the 9L rat brain cell line. Anti-Cancer Res 13: 2137-2142, 1993.
6. Carde P and Laval F: Effect of cis-dichlorodiamine platinum II and X-rays on mammalian cell survival. Int J Radiat Oncol 7: 429-933, 1981.
7. Schwachofer JHM, Crooijmans RPMA, Hoogenhout J, Kal HB and Theeuwes AGM: Effectiveness in inhibition of recovery of cell survival by cisplatin and carboplatin influence oftreatment sequence. Int J Radiat Oncol 20: 1235-1241, 1991.
8. Wallner KE and Li GC: Effect of cisplatin resistance on cellular radiation response. Int J Radiat Oncol 13: 587-591, 1987.
9. Douple EB: Interaction between cisplatin coordination complexes and radiation. In: Antiturnour drug-radiation interactions. (Hill BT and Bellamy AS, eds) Boca Raton, Florida: CRC Press, 171-190, 1990.
10. Szumiel I and Nias AHW: The effect of combined treatment with a platinum complex and ionizing radiation of Chinese hamster ovary cells in vitro. Br J Cancer 33: 450-458, 1976.
11. Raaphorst GP, Wang G, Stewart D, and Ng CE: A study of cisplatinradiosensitization through inhibition of repair of sublethal radiation damage in ovarian carcinoma cells sensitive and resistant to cisplatin. Int J Oncol 7: 1373-1378, 1995.
12. Raaphorst GP, Mao JP and Ng CE: Sublethal radiaiton damage repair and its inhibition by hypertherrnia in two human melanoma cell lines of different radiosensitivity. Melanoma Res 4: 157-161, 1994.
13. Raaphorst GP, Mao JP and Ng CE: Repair of potentially lethal damage: Its inhibition by hypertherrnia in two melanoma cell lines with different radio- and heat sensitivities. Melanoma Res 3: 351-356, 1993.
14. Li GC, Evans RG and Hahn GM: Modification and inhibition of repair of potentially lethal X-ray damage by hyperthermia. Radiat Res 67: 491-501, 1976.
15. Raaphorst GP, Yang DP, Bussey A, and Ng CE: Cell killing DNA polymerase inactiviation and radiosensitization to low dose rate irradiation by mild hyperthermia in four human cell lines. Int J Hypertherm 11(6): 841-854, 1995.
16. Raaphorst GP, Bussey A, Heller DP and Ng CE: Comparison of thermoradiosensitization in two human melanoma cell lines and one fibroblast cell line by concurrent mild hyperthermia and low-dose-rate irradiation. Radiat Res 137: 338-345, 1994.
17. Armour EP, Wang Z, Corry PM and Martinez A: Sensitization of rat 9L gliosarcoma cells to low dose rate irradiation by long duration 41°C hyperthermia. Cancer Res 51: 3088-3095, 1991.
18. Wilkins DE, Ng CE and Raaphorst GP: Cisplatin and low dose rate irradiation in cisplatin resistant and sensitive human glioma cells. Int J Radiat Oncol 36: 105-111, 1996.
19. Raaphorst GP, Miao J, Stewart D, and Ng CE: Interactions of mild hyperthermia, cisplatin and split dose, irradiation in human ovarian carcinoma cells. Cancer Chemother. Pharmacol 37: 574-580, 1996.
20. 1 or late S phase. Cancer Res 53: 1239-1243, 1993.
21. Raaphorst GP, Chabot P, Doja S et al: Effect of hyperthermia on cisplatin sensitivity in human glioma and ovarian carcinoma cell lines resistant and sensitive to cisplatin treatment. Int J Hypertherm 12(2): 211-222, 1996.
22. Hamilton TC, Lai GM, Rothenberg LM, Fojo AT, Young RC and Ozols RF: Mechanisms of resistance to cisplatin and alkylating agents, In: Drug Resistance in Cancer Therapy, edited by Ozols, RF Boston: Kluwer Academic Publishers, 151-169, 1989.
23. Heller DP and Raaphorst GP: Low dose-rate irradiation of human glioma cells and thermoradiosensitization by mild hyperthermia. Radiation Oncology Investigations 1: 218-226, 1993.